slide1 l.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
WP 2: Dosimetry PowerPoint Presentation
Download Presentation
WP 2: Dosimetry

Loading in 2 Seconds...

play fullscreen
1 / 40

WP 2: Dosimetry - PowerPoint PPT Presentation


  • 193 Views
  • Uploaded on

WP 2: Dosimetry. WP2.4. development of simulation environment. simulation of patient dose with mathematical models. Overview. Scheme Consortium meeting 2009. WP2.5. WP2.3. WP2.2. development of methodology/ initial measurements. development of methodology/ initial measurements.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'WP 2: Dosimetry' - evers


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
slide2

WP2.4

development of simulation environment

simulation of patient dose with mathematical models

Overview

Scheme Consortium meeting 2009

WP2.5

WP2.3

WP2.2

development of methodology/

initial measurements

development of methodology/

initial measurements

development of methodology/

initial measurements

WP2.1

decision on equipment and methodology

PROTOCOL

PROTOCOL

PROTOCOL

design of

standard phantom

development of

standard dose indices

measurement of dose in phantom for range of CBCTs

in vivo TLD

skin dose measurements

scatter dose measurements

measurement of indices on range of CBCTs

Leuven, Manchester, involvement of Malmö and Leeds for standard dose index and phantom

Leuven, Manchester, Athens, Malmö

Leuven, Manchester, Athens, Vilnius

Manchester, Athens

slide3

WP2.4

development of simulation environment

simulation of patient dose with mathematical models

Overview

Current scheme

WP2.5

WP2.3

WP2.2

development of methodology/

initial measurements

development of methodology/

initial measurements

development of methodology/

initial measurements

WP2.1

decision on equipment and methodology

PROTOCOL

PROTOCOL

PROTOCOL

development of

standard dose indices

(M2.1)

design of

standard phantom

measurement of dose in phantom for range of CBCTs (M2.2)

in vivo TLD

skin dose measurements

(M2.3)

scatter dose measurements

VALIDATION OF INDICES

M2.4

measurement of indices on range of CBCTs

M2.5

M2.6

Leuven, Manchester, involvement of Malmö and Leeds for standard dose index and phantom

Leuven, Manchester, Athens, Malmö

Leuven, Manchester, Athens, Vilnius

Manchester, Athens

slide4

Overview

M2.1 Definition of standard dose index

M2.2 Conclusion on dose distribution in anatomical phantoms

M2.3 Results of in vivo measurements

M2.5 Mathematical models developed and confirmed

M2.6 Determination of effective dose and conversion factors for representative operating conditions and CBCT equipment

T0

35

17

23

26

29

M2.4 Completion of scatter dose measurements and recommendations for protection of personnel

slide6

WP2.1 Standardised dose index for CBCTKU LeuvenUniversity of ManchesterLeeds Test Objects Malmö University

slide7

2.1 Dose index

  • Design and fabrication of PMMA dosimetry phantom (UNIMAN, LTO)
  • Discussion technical/risk-related index
  • Measurements:

in PMMA phantom (UNIMAN)

- TLD

- Film

in water phantom (KUL)

- TLD (grid)

- pencil ion chamber

in anthropomorphic phantom (WP 2.2) (KUL+UNIMAN)

  • Dose index definition(Milestone 2.1, Month 18,finaldeliverable report Month 21)
2 1 dose index
2.1 Dose index
  • Film measurements:
  • Resolution ↑↑
  • Calibrationforquantitativeresults?
3 indices defined

FOV at the central axis

Measuring points

FOV off central axis

Phantom

2.1 Dose index

3 indices defined

1

Phantom

FOV axis

2

Measuring points

Phantom

3 indices defined12

2.1 Dose index

3 indices defined

Dose-area product (DAP)

3

slide13

2.1 Dose index

1

Validation in practice? CRUCIAL (change of DoW)

2

  • Design of validationphantom (basedon PMMAdosimetryphantom, canaccomodate ion chamber,TLD and film)
  • Evaluation of the 3 dose indices withthisphantom
  • Decisiononstandardphantom

3

slide15

2.2 Anatom. phantom

ADULT PHANTOM

PAEDIATRIC PHANTOMS

slide16

2.2 Anatom. phantom

  • Largenumber of effectivedosemeasurementsobtained(Milestone 2.2, Month 18)
  • ADULT PHANTOM
  • -15 different CBCT devices
  • Accuitomo 170 Galileos I-CAT Classic I-CAT NextGenerationIluma Kodak 9000
  • Kodak 9500 NewTom VG NewTomVGi
  • PaxUni 3D Picasso Trio ProMax 3D
  • Scanora 3D SkyviewVeraviewepocs 3D
  • - Multiple exposureprotocols / field positionings
slide18

2.2 Anatom. phantom

Imaging Protocols

10 year old phantom

2.2 Anatom. phantom

10 year old phantom

Max: maxillofacial, Den: dental, Mand: Mandible, Max: Maxilla, Imp: maxillary impacted teeth, Acc: 3D Accuitomo 170, HR: high resolution, Default: default machine’s settings, LR: left & right

adolescent phantom

2.2 Anatom. phantom

Adolescent phantom

Max: maxillofacial, Den: dental, Mand: Mandible, Max: Maxilla, Max Wisd: maxillary wisdom, Acc: 3D Accuitomo 170, Default: default machine’s settings

effective doses

2.2 Anatom. phantom

Effective doses
  • 10 year old effective dose
    • Average = 40μSv, minimum = 5μSv, maximum=99 μSv
  • Adolescent Phantom
    • Average=29μSv, minimum=3.5μSv, maximum=62 μSv
  • % radiation-induced fatal cancer risk to children:
    • 10 year old = 0.0004% and teenager = 0.00029%
  • Lower EDs for the Adolescent because of bigger size
    • Exception: Acc Molar + NewTom → Difference in mAs
  • Promax 3D:
    • Lowest → Small FOV, kV + mAs and 220o rotation
  • I -CAT 13cm + Acc 17x12 highest:
    • Full FOVs
  • Accuitomo:
    • Difference between 17x5 and 17x12
    • 180o rotation reduces the dose by 50% and more
contribution to effective dose

2.2 Anatom. phantom

% contribution to effective dose
  • % organ contribution to effective dose
    • 10 year old phantom= similar contribution from RBM, thyroid, salivary glands
    • Adolescent phantom= higher contribution from salivary glands and thyroid because of size
  • Both phantoms
    • RBM contribution similar
    • RBM low doses but high radiosensitivity
    • Small contribution from skin and brain
slide23

2.2 Anatom. phantom

  • Currently
  • MeasurementscontinuedafterMilestone 2.2
  • Multiple measurementsneededfor most devices, for correct assessment of effectivedose range
  • Adultphantomintercomparison
  • Paediatricphantoms

Publications

The current results are being compiled into two separate manuscripts: one containing adult measurements and another for the paediatric measurements.

slide24

WP2.3 In vivo dose measurements KU Leuven University of Manchester University of AthensVilnius University

slide25

2.3 In vivodose

  • TLD intercomparison: - compare TLD absorbed doses to ion chamberdose in two set- ups for Manchester, Leuven, Athens and Vilnius- anomalyfor Leuven solved
  • Measurementresults (Milestone 2.3 Month 24): >150 measurementsaccording to established protocol obtainedfrom different partners (KUL, VU, NKUA)
  • Currently:- gathering and analyzingresults- additionalmeasurementsforfilling in gaps (agegroup, indication,measurements at UNIMAN ifpossible (ethicalconstraints))
slide26

2.3 In vivodose

Vilnius

Number of patients until 2009/11/21

Diagnosis:

Implant (both jaws) - IM

Canine - CAN

38/48 - WT

Orthodontic/surgery upper jaw – OS-U

Orthodontic/surgery lower jaw –OS L

Maxillary sinus- MS

slide28

2.4 Math. models

  • Development of mathematical models for dental CBCT dosimetry:
    • factors to convert from measured standard dose indices and in-vivo skin dose measurement to effective dose
  • Calculation of conversion factors using Monte Carlo (MC) simulations (UNIMAN)
  • MC simulations are a class of computational algorithms that are based on repeated random sampling to compute the results
  • MCNP: a general purpose Monte Carlo N-Particle code
    • neutron, photon, electron or coupled neutron/photon/electron transport
    • tracks all particles at all energies that are necessary for these simulations
    • all interactions (cross-sections) between photons and matter are taken into account
slide29

2.4 Math. models

Monte Carlo N-Particle code

  • Modelling the source
    • MCNP offers point, area, volume and multiple sources
    • Biasing direction & energy
  • Modelling the geometry
    • Planes, cylinders, spheres, cones and macrobodies like a box
    • Based on the above simple geometrical model you could build
      • Analytical phantoms
      • Voxel phantoms
  • Tallies = Output
    • Fluence, surface fluence, average fluence in a cell, energy fluence, energy deposition, pulse height
  • Input file describes:
    • Geometry in terms of cells and surfaces
    • Source
    • Materials
    • Particles involved
    • Tallies
  • MCNP5 installed on a cluster of 8 dedicated PCs and run under Linux operating system
slide30

2.4 Math. models

Modelling the Source

  • Point source with forward biased direction
    • Biased direction: sends photons to the right direction
  • Source is a circular cone if the direction is biased
    • Set of 4 collimators, similar to X-ray tube, to shape the beam to a square (pyramidal)
  • MCNP5 does not offer moving sources
  • CT scanner is modelled with several point sources positioned on a “ring”
    • For a 360o rotation: 36 sources every 10 degrees
    • For a 180o rotation: 18 sources every 10 degrees
slide31

2.4 Math. models

Modelling the Source, Collimators

and Energy spectrum

  • Report 78 Spectrum Processor
  • 3D Accuitomo 170, 85kV and 90kV with 3.1mm Al filtration
  • Spectra normalised to area and used as input for MCNP5
slide32

2.4 Math. models

Validation with a PMMA phantom

  • Cylinder of PMMA
    • 16cm diameter, 20cm height
  • Centre of the cylinder placed at the isocentre of the beam
  • 10x10 FOV
slide33

2.4 Math. models

Validation with a PMMA phantom

  • Extensive tests were run to assess:
    • Point sources
    • Direction of particles for every point source
    • Position and size of collimators
    • Energy spectrum
    • Number of particles emitted from every source
    • Position and material of cylinder
    • Use of several tallies like fluence, surface, energy and cell fluence and energy deposition
  • Energy deposition (mGy/particle) calculated for a cell (2 x 2 x 2 cm3) in the middle of the cylinder
  • Energy deposited for two geometries:
    • Cylinder and cell made of air
    • Cylinder and cell made of PMMA
  • Ratio of the energy deposited for both geometries was calculated
  • For both energies % difference between simulated and experimental ratios was <14%
slide34

2.4 Math. models

Future work

  • PMMA geometry
    • More energies
    • A range of positions in the cylinder
    • Axis and off-axis geometries
    • Range of field of views
  • Antropomorphic phantoms
    • Voxelise the two paediatric + ART phantoms
    • Validation on the 3D Accuitomo 170 Validation on other CBCT units
    • Use of other available voxel phantoms and compare with ATOM phantoms
    • List of conversion factors for a range of geometries and dental CBCT units
slide35

WP2.5: Measurements of scatter dose and radiation protection of personnel and helpersUniversity of ManchesterAthens UniversityVilnius UniversityKU Leuven

protocol

2.5 Scatterdose

Protocol
  • Active measurements
    • Using ionisation chamber or dose rate meter
    • On standard measurement grid
  • Passive dosimetry
    • High sensitivity TLD badges
    • In rooms where CBCT is sole x­ray source
scatter measurements
Are/Will be carried out on:

Kodak 9000

Vatech Picasso Trio

Vatech Pax Uni 3D

Myray Skyview

NewTom VGi

NewTom 9000

NewTom VG

Morita 3D Accuitomo

Morita Veraviewepocs 3D

Planmeca ProMax 3D

Soredex Scanora 3D

Sirona Galileos

In:

UK

Greece

Belgium

Lithuania

2.5 Scatterdose

Scatter measurements
slide39

2010 SCHEDULE

M2.4 Completion of scatter dose measurements and recommendations for protection of personnel

M2.5 Mathematical models developed and confirmed

M2.6 Determination of effective dose and conversion factors for representative operating conditions and CBCT equipment

T0

35

17

23

26

29

WP2.1 Validatedose indices in plexiphantom, final design of standardphantom, start concludingmeasurements in standardphantom.

WP2.2 Additionalmeasurementsdependingopportunities

WP2.3 Additionalmeasurementsdependingonopportunities, measurements in Manchester ifethical issues are solved

WP2.4 Continue and finish set-up and validation of MC framework, simulatedosedistributions, determineeffectivedose and calculateconversion factors (M2.5 and 2.6)

WP2.5 Completion of scatter dose measurements around CBCTs and recommendations for protective measures and positioning of CBCT units in dental offices (M2.4)

change of dow
Change of DoW

3

1

2

  • Dose index validation in practice?CRUCIAL
  • - definition has not been straightforward (variety of scanners and parameters)
  • large impact (objectiveway of comparing doses of CBCTs, impact on vendor data, decisions in acquisitionprocess, tasks of medicalphysicists
  • Simulationworkwithradiotherapy planning system:less relevant
  • Back-up for MC calculationsbutlessadvanced and more experimental(kV beamsinstead of MV beams)
  • Muchexperimentalpreparatoryworkthatcannotbeusedforother WP2 objectives
  • Initialchoice:
    • versatile system forquickdosepredictionfor different geometries nowmanyexperimental data available in WP2.2
    • simulation expertise at KUL now MC expertise in parallel project